Publications

* Common and rare GCH1 variants are associated with Parkinson’s disease (Rudakou et al, 2019)

* SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson’s disease (Alcalay et al, 2019)

* Parkinson’s disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms (Blauwendraat et al, 2019)

* Transcranial magnetic stimulation improves cognition over time in Parkinson’s disease (Trung et al, 2019)

* Why Is Aging a Risk Factor for Cognitive Impairment in Parkinson’s Disease? A Resting State fMRI Study (Nagano-Saito et al, 2019)

* TOX3 Variants Are Involved in Restless Legs Syndrome and Parkinson’s Disease with Opposite Effects (Mohtashami et al, 2018)

* Association study of essential tremor genetic loci in Parkinson’s disease (Ross et al, 2018)

Full sequencing and haplotype analysis of MAPT in Parkinson’s disease and rapid eye movement sleep behavior disorder (Li  et al, 2018)

* Sequencing of the GBA coactivator, Saposin C, in Parkinson disease (Ouled Amar Bencheikh et al, 2018)

* Frequency of Loss of Function Variants in LRRK2 in Parkinson Disease (Blauwendraat et al, 2018)

* The GBA p.Trp378Gly mutation is a probable French-Canadian founder mutation causing Gaucher disease and synucleinopathies (Ruskey et al, 2018)

* White matter degeneration profile in the cognitive cortico-subcortical tracts in Parkinson’s disease. Movement Disorders. (Hanganu et al, 2018)

* Cardinal motor features of Parkinson’s disease coexist with peak-dose choreic-type drug-induced dyskinesia. Parkinson’s symptoms coexist with dyskinesia (Goubault et al, 2018)

*  Cranio-Caudal Kinematic Turn Signature Assessed with Inertial Systems As a Marker of Mobility Deficits in Parkinson’s Disease (Lebel et al, 2018)

* The influence of vascular risk factors on cognitive function in early Parkinson’s disease (Doiron et al, 2018)

Auto detection and segmentation of daily living activities during a Timed Up and Go task in people with Parkinson’s disease using multiple inertial sensors (Nguyen et al, 2017)

* REM Sleep Behavior Disorder and Cognitive Impairment in Parkinson’s Disease (Jozwiak et al, 2017)

Depressive symptoms in Parkinson’s disease correlate with cortical atrophy over time (Hanganu et al, 2017)

* Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson’s disease (Blauwendraat et al, 2017)

RIC3 variants are not associated with Parkinson’s disease in French-Canadian and French (Ross et al, 2017)

* Dementia Predictors in Parkinson Disease: A Validation Study (Anang et al, 2017)

* Smoking history is associated to cognitive impairment in Parkinson’s disease (Doiron et al, 2017)

* A 12-Week Cycling Training Regimen Improves Gait and Executive Functions Concomitantly in People with Parkinson’s Disease (Nadeau et al, 2017)

* Structural Neuroimaging Markers of Cognitive Decline in Parkinson’s Disease (Hanganu & Monchi, 2016)

* Markers of cognitive decline in PD: The case for heterogeneity (monchi et al, 2016)

* Risk Factor Profile in Parkinson’s Disease Subtype with REM Sleep Behavior Disorder (Jacobs, 2016)

Analysis of DNAJC13 mutations in French-Canadian/French cohort of Parkinson’s disease (Ross et al, 2016)

Patterns of Longitudinal Neural Activity Linked to Different Cognitive Profiles in Parkinson’s Disease (Nagano-Saito et al, 2016)

* Tango for treatment of motor and non-motor manifestations in Parkinson’s disease: a randomized control study (Romenets et al, 2015)

Influence of depressive symptoms on dopaminergic treatment of Parkinson’s disease (Hanganu, 2014)

———————————————————————————————————————————————

Congrès

Professional exposure to pesticides and heavy metals hastens the onset of Parkinson disease (Avril 2017)

Congrès de l’American Academy of Neurology